2023 Q2 Form 10-Q Financial Statement
#000145247723000018 Filed on April 25, 2023
Income Statement
Concept | 2023 Q2 | 2023 Q1 | 2022 Q1 |
---|---|---|---|
Revenue | $9.090M | $9.347M | $13.78M |
YoY Change | 21.23% | -32.16% | 588.51% |
Cost Of Revenue | $9.000M | $8.766M | $2.800M |
YoY Change | 121.13% | 213.07% | 291.61% |
Gross Profit | $8.020M | $8.275M | $12.71M |
YoY Change | 24.63% | -34.91% | 888.65% |
Gross Profit Margin | 88.23% | 88.53% | 92.28% |
Selling, General & Admin | $1.470M | $796.0K | $946.0K |
YoY Change | 6.68% | -15.86% | 59.8% |
% of Gross Profit | 18.33% | 9.62% | 7.44% |
Research & Development | |||
YoY Change | |||
% of Gross Profit | |||
Depreciation & Amortization | $0.00 | ||
YoY Change | |||
% of Gross Profit | 0.0% | ||
Operating Expenses | $3.130M | $452.0K | $1.506M |
YoY Change | 72.17% | -69.99% | 64.05% |
Operating Profit | $4.890M | $7.823M | $11.21M |
YoY Change | 5.91% | -30.2% | 2945.65% |
Interest Expense | $7.927M | $7.694M | $1.737M |
YoY Change | 163.62% | 342.95% | |
% of Operating Profit | 162.11% | 98.35% | 15.5% |
Other Income/Expense, Net | |||
YoY Change | |||
Pretax Income | $4.671M | $7.823M | $11.17M |
YoY Change | 1.17% | -29.97% | 2935.6% |
Income Tax | $27.00K | $20.00K | $45.00K |
% Of Pretax Income | 0.58% | 0.26% | 0.4% |
Net Earnings | $4.644M | $7.803M | $11.13M |
YoY Change | 1.44% | -29.87% | 3078.86% |
Net Earnings / Revenue | 51.09% | 83.48% | 80.76% |
Basic Earnings Per Share | $0.32 | $0.53 | $0.76 |
Diluted Earnings Per Share | $0.32 | $0.53 | $0.76 |
COMMON SHARES | |||
Basic Shares Outstanding | 14.71M shares | 14.71M shares | 14.51M shares |
Diluted Shares Outstanding | 14.61M shares | 14.58M shares | 14.52M shares |
Balance Sheet
Concept | 2023 Q2 | 2023 Q1 | 2022 Q1 |
---|---|---|---|
SHORT-TERM ASSETS | |||
Cash & Short-Term Investments | $81.80M | $84.30M | $8.953M |
YoY Change | 69.6% | 841.58% | -80.89% |
Cash & Equivalents | $81.81M | $84.30M | $8.953M |
Short-Term Investments | |||
Other Short-Term Assets | $1.500M | $1.176M | $3.353M |
YoY Change | -51.74% | -64.93% | 999.34% |
Inventory | |||
Prepaid Expenses | |||
Receivables | |||
Other Receivables | |||
Total Short-Term Assets | $83.30M | $85.48M | $12.31M |
YoY Change | 62.26% | 594.59% | -73.9% |
LONG-TERM ASSETS | |||
Property, Plant & Equipment | |||
YoY Change | |||
Goodwill | |||
YoY Change | |||
Intangibles | |||
YoY Change | |||
Long-Term Investments | $622.7M | ||
YoY Change | 322.9% | ||
Other Assets | $200.0K | $8.000K | $9.000K |
YoY Change | 20.48% | -11.11% | -95.91% |
Total Long-Term Assets | $644.6M | $621.3M | $622.7M |
YoY Change | -3.84% | -0.23% | 320.98% |
TOTAL ASSETS | |||
Total Short-Term Assets | $83.30M | $85.48M | $12.31M |
Total Long-Term Assets | $644.6M | $621.3M | $622.7M |
Total Assets | $727.9M | $706.8M | $635.0M |
YoY Change | 0.86% | 11.3% | 225.54% |
SHORT-TERM LIABILITIES | |||
YoY Change | |||
Accounts Payable | $4.300M | $3.262M | $967.0K |
YoY Change | 261.04% | 237.33% | -13.74% |
Accrued Expenses | |||
YoY Change | |||
Deferred Revenue | |||
YoY Change | |||
Short-Term Debt | $0.00 | $0.00 | $0.00 |
YoY Change | |||
Long-Term Debt Due | |||
YoY Change | |||
Total Short-Term Liabilities | $7.400M | $5.633M | $2.093M |
YoY Change | 228.31% | 169.14% | 14.81% |
LONG-TERM LIABILITIES | |||
Long-Term Debt | $452.7M | $433.4M | $367.7M |
YoY Change | 0.0% | 17.87% | |
Other Long-Term Liabilities | |||
YoY Change | |||
Total Long-Term Liabilities | $452.7M | $433.4M | $367.7M |
YoY Change | 0.0% | 17.87% | |
TOTAL LIABILITIES | |||
Total Short-Term Liabilities | $7.400M | $5.633M | $2.093M |
Total Long-Term Liabilities | $452.7M | $433.4M | $367.7M |
Total Liabilities | $460.1M | $439.0M | $369.8M |
YoY Change | 1.13% | 18.73% | 20183.71% |
SHAREHOLDERS EQUITY | |||
Retained Earnings | $58.14M | $53.50M | $35.78M |
YoY Change | 44.08% | 49.54% | 10121.71% |
Common Stock | $239.2M | $238.6M | $237.7M |
YoY Change | 0.38% | 0.38% | 23.24% |
Preferred Stock | |||
YoY Change | |||
Treasury Stock (at cost) | |||
YoY Change | |||
Treasury Stock Shares | |||
Shareholders Equity | $267.8M | $267.7M | $265.3M |
YoY Change | |||
Total Liabilities & Shareholders Equity | $727.9M | $706.8M | $635.0M |
YoY Change | 0.86% | 11.3% | 225.54% |
Cashflow Statement
Concept | 2023 Q2 | 2023 Q1 | 2022 Q1 |
---|---|---|---|
OPERATING ACTIVITIES | |||
Net Income | $4.644M | $7.803M | $11.13M |
YoY Change | 1.44% | -29.87% | 3078.86% |
Depreciation, Depletion And Amortization | $0.00 | ||
YoY Change | |||
Cash From Operating Activities | $5.030M | $6.577M | $3.085M |
YoY Change | 56.11% | 113.19% | -322.74% |
INVESTING ACTIVITIES | |||
Capital Expenditures | |||
YoY Change | |||
Acquisitions | |||
YoY Change | |||
Other Investing Activities | -$21.09M | $50.27M | -$44.61M |
YoY Change | -53.03% | -212.68% | -18.95% |
Cash From Investing Activities | -$21.09M | $50.27M | -$44.61M |
YoY Change | -53.03% | -212.68% | -18.95% |
FINANCING ACTIVITIES | |||
Cash Dividend Paid | $5.147M | $3.649M | |
YoY Change | 41.05% | ||
Common Stock Issuance & Retirement, Net | |||
YoY Change | |||
Debt Paid & Issued, Net | |||
YoY Change | |||
Cash From Financing Activities | 13.79M | -$43.60M | $24.19M |
YoY Change | -83.0% | -280.22% | -31934.21% |
NET CHANGE | |||
Cash From Operating Activities | 5.030M | $6.577M | $3.085M |
Cash From Investing Activities | -21.09M | $50.27M | -$44.61M |
Cash From Financing Activities | 13.79M | -$43.60M | $24.19M |
Net Change In Cash | -2.270M | $13.24M | -$17.33M |
YoY Change | -105.76% | -176.39% | -69.32% |
FREE CASH FLOW | |||
Cash From Operating Activities | $5.030M | $6.577M | $3.085M |
Capital Expenditures | |||
Free Cash Flow | |||
YoY Change |
Facts In Submission
Frame | Concept Type | Concept / XBRL Key | Value | Unit |
---|---|---|---|---|
CY2023Q1 | dei |
Entity Address Address Line2
EntityAddressAddressLine2
|
255 Washington Street | |
CY2023Q1 | dei |
Entity Central Index Key
EntityCentralIndexKey
|
0001452477 | |
CY2023Q1 | dei |
Amendment Flag
AmendmentFlag
|
false | |
CY2023Q1 | dei |
Current Fiscal Year End Date
CurrentFiscalYearEndDate
|
--12-31 | |
CY2023Q1 | dei |
Document Fiscal Year Focus
DocumentFiscalYearFocus
|
2023 | |
CY2023Q1 | dei |
Document Fiscal Period Focus
DocumentFiscalPeriodFocus
|
Q1 | |
CY2022 | us-gaap |
Accounting Standards Update Extensible List
AccountingStandardsUpdateExtensibleList
|
http://fasb.org/us-gaap/2022#AccountingStandardsUpdate201613Member | |
CY2023Q1 | dei |
Document Type
DocumentType
|
10-Q | |
CY2023Q1 | dei |
Document Quarterly Report
DocumentQuarterlyReport
|
true | |
CY2023Q1 | dei |
Document Period End Date
DocumentPeriodEndDate
|
2023-03-31 | |
CY2023Q1 | dei |
Document Transition Report
DocumentTransitionReport
|
false | |
CY2023Q1 | dei |
Entity File Number
EntityFileNumber
|
001-34383 | |
CY2023Q1 | dei |
Entity Registrant Name
EntityRegistrantName
|
Seven Hills Realty Trust | |
CY2023Q1 | dei |
Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
|
MD | |
CY2023Q1 | dei |
Entity Tax Identification Number
EntityTaxIdentificationNumber
|
20-4649929 | |
CY2023Q1 | dei |
Entity Address Address Line1
EntityAddressAddressLine1
|
Two Newton Place | |
CY2023Q1 | dei |
Entity Address Address Line3
EntityAddressAddressLine3
|
Suite 300 | |
CY2023Q1 | dei |
Entity Address City Or Town
EntityAddressCityOrTown
|
Newton | |
CY2023Q1 | dei |
Entity Address State Or Province
EntityAddressStateOrProvince
|
MA | |
CY2023Q1 | dei |
Entity Address Postal Zip Code
EntityAddressPostalZipCode
|
02458-1634 | |
CY2023Q1 | dei |
City Area Code
CityAreaCode
|
617 | |
CY2023Q1 | dei |
Local Phone Number
LocalPhoneNumber
|
332-9530 | |
CY2023Q1 | dei |
Security12b Title
Security12bTitle
|
Common Shares of Beneficial Interest | |
CY2023Q1 | dei |
Trading Symbol
TradingSymbol
|
SEVN | |
CY2023Q1 | dei |
Security Exchange Name
SecurityExchangeName
|
NASDAQ | |
CY2023Q1 | dei |
Entity Current Reporting Status
EntityCurrentReportingStatus
|
Yes | |
CY2023Q1 | dei |
Entity Interactive Data Current
EntityInteractiveDataCurrent
|
Yes | |
CY2023Q1 | dei |
Entity Filer Category
EntityFilerCategory
|
Non-accelerated Filer | |
CY2023Q1 | dei |
Entity Small Business
EntitySmallBusiness
|
true | |
CY2023Q1 | dei |
Entity Emerging Growth Company
EntityEmergingGrowthCompany
|
false | |
CY2023Q1 | dei |
Entity Shell Company
EntityShellCompany
|
false | |
CY2023Q2 | dei |
Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
|
14706862 | shares |
CY2023Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
84300000 | usd |
CY2022Q4 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
71057000 | usd |
CY2023Q1 | us-gaap |
Restricted Cash
RestrictedCash
|
8000 | usd |
CY2022Q4 | us-gaap |
Restricted Cash
RestrictedCash
|
10000 | usd |
CY2023Q1 | us-gaap |
Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
|
622070000 | usd |
CY2022Q4 | us-gaap |
Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
|
669929000 | usd |
CY2023Q1 | us-gaap |
Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
|
4135000 | usd |
CY2022Q4 | us-gaap |
Financing Receivable Allowance For Credit Loss Excluding Accrued Interest
FinancingReceivableAllowanceForCreditLossExcludingAccruedInterest
|
0 | usd |
CY2023Q1 | us-gaap |
Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
|
617935000 | usd |
CY2022Q4 | us-gaap |
Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
|
669929000 | usd |
CY2023Q1 | us-gaap |
Financing Receivable Accrued Interest After Allowance For Credit Loss
FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss
|
3346000 | usd |
CY2022Q4 | us-gaap |
Financing Receivable Accrued Interest After Allowance For Credit Loss
FinancingReceivableAccruedInterestAfterAllowanceForCreditLoss
|
3354000 | usd |
CY2023Q1 | us-gaap |
Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
|
1176000 | usd |
CY2022Q4 | us-gaap |
Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
|
2497000 | usd |
CY2023Q1 | us-gaap |
Assets
Assets
|
706765000 | usd |
CY2022Q4 | us-gaap |
Assets
Assets
|
746847000 | usd |
CY2023Q1 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
3262000 | usd |
CY2022Q4 | us-gaap |
Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
|
1903000 | usd |
CY2023Q1 | us-gaap |
Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
|
433385000 | usd |
CY2022Q4 | us-gaap |
Secured Debt Repurchase Agreements
SecuredDebtRepurchaseAgreements
|
471521000 | usd |
CY2023Q1 | us-gaap |
Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
|
2371000 | usd |
CY2022Q4 | us-gaap |
Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
|
1844000 | usd |
CY2023Q1 | us-gaap |
Liabilities
Liabilities
|
439018000 | usd |
CY2022Q4 | us-gaap |
Liabilities
Liabilities
|
475268000 | usd |
CY2023Q1 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2022Q4 | us-gaap |
Commitments And Contingencies
CommitmentsAndContingencies
|
usd | |
CY2023Q1 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2022Q4 | us-gaap |
Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
|
0.001 | |
CY2023Q1 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
25000000 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Authorized
CommonStockSharesAuthorized
|
25000000 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
14706862 | shares |
CY2023Q1 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
14706862 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Issued
CommonStockSharesIssued
|
14709165 | shares |
CY2022Q4 | us-gaap |
Common Stock Shares Outstanding
CommonStockSharesOutstanding
|
14709165 | shares |
CY2023Q1 | us-gaap |
Common Stock Value
CommonStockValue
|
15000 | usd |
CY2022Q4 | us-gaap |
Common Stock Value
CommonStockValue
|
15000 | usd |
CY2023Q1 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
238612000 | usd |
CY2022Q4 | us-gaap |
Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
|
238505000 | usd |
CY2023Q1 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
53498000 | usd |
CY2022Q4 | us-gaap |
Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
|
52290000 | usd |
CY2023Q1 | us-gaap |
Cumulative Dividends
CumulativeDividends
|
24378000 | usd |
CY2022Q4 | us-gaap |
Cumulative Dividends
CumulativeDividends
|
19231000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
267747000 | usd |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
271579000 | usd |
CY2023Q1 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
706765000 | usd |
CY2022Q4 | us-gaap |
Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
|
746847000 | usd |
CY2023Q1 | us-gaap |
Interest Income Operating
InterestIncomeOperating
|
15856000 | usd |
CY2022Q1 | us-gaap |
Interest Income Operating
InterestIncomeOperating
|
9579000 | usd |
CY2023Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
1185000 | usd |
CY2022Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
5935000 | usd |
CY2023Q1 | us-gaap |
Interest Expense
InterestExpense
|
7694000 | usd |
CY2022Q1 | us-gaap |
Interest Expense
InterestExpense
|
1737000 | usd |
CY2023Q1 | us-gaap |
Net Investment Income
NetInvestmentIncome
|
9347000 | usd |
CY2022Q1 | us-gaap |
Net Investment Income
NetInvestmentIncome
|
13777000 | usd |
CY2023Q1 | sevn |
Base Management Fee
BaseManagementFee
|
1072000 | usd |
CY2022Q1 | sevn |
Base Management Fee
BaseManagementFee
|
1063000 | usd |
CY2023Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
796000 | usd |
CY2022Q1 | us-gaap |
General And Administrative Expense
GeneralAndAdministrativeExpense
|
872000 | usd |
CY2023Q1 | sevn |
Reimbursement Of Shared Services Expenses
ReimbursementOfSharedServicesExpenses
|
643000 | usd |
CY2022Q1 | sevn |
Reimbursement Of Shared Services Expenses
ReimbursementOfSharedServicesExpenses
|
634000 | usd |
CY2023Q1 | us-gaap |
Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
|
-987000 | usd |
CY2022Q1 | us-gaap |
Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
|
0 | usd |
CY2023Q1 | sevn |
Other Transaction Related Costs
OtherTransactionRelatedCosts
|
0 | usd |
CY2022Q1 | sevn |
Other Transaction Related Costs
OtherTransactionRelatedCosts
|
37000 | usd |
CY2023Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
1524000 | usd |
CY2022Q1 | us-gaap |
Costs And Expenses
CostsAndExpenses
|
2606000 | usd |
CY2023Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
7823000 | usd |
CY2022Q1 | us-gaap |
Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
|
11171000 | usd |
CY2023Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
20000 | usd |
CY2022Q1 | us-gaap |
Income Tax Expense Benefit
IncomeTaxExpenseBenefit
|
45000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
7803000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
11126000 | usd |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
14582000 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
14505000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14582000 | shares |
CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14519000 | shares |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.53 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.53 | |
CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.76 | |
CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.76 | |
CY2022Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
271579000 | usd |
CY2023Q1 | us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
121000 | usd |
CY2023Q1 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
13000 | usd |
CY2023Q1 | us-gaap |
Stock Issued During Period Value Share Based Compensation Forfeited
StockIssuedDuringPeriodValueShareBasedCompensationForfeited
|
1000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
7803000 | usd |
CY2023Q1 | us-gaap |
Dividends Common Stock Cash
DividendsCommonStockCash
|
5147000 | usd |
CY2023Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
267747000 | usd |
CY2021Q4 | us-gaap |
Stockholders Equity
StockholdersEquity
|
257694000 | usd |
CY2022Q1 | us-gaap |
Stock Granted During Period Value Sharebased Compensation
StockGrantedDuringPeriodValueSharebasedCompensation
|
82000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
11126000 | usd |
CY2022Q1 | us-gaap |
Dividends Common Stock Cash
DividendsCommonStockCash
|
3649000 | usd |
CY2022Q1 | us-gaap |
Stockholders Equity
StockholdersEquity
|
265253000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
7803000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
11126000 | usd |
CY2023Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
1185000 | usd |
CY2022Q1 | us-gaap |
Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
|
5935000 | usd |
CY2023Q1 | us-gaap |
Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
|
-987000 | usd |
CY2022Q1 | us-gaap |
Provision For Loan Losses Expensed
ProvisionForLoanLossesExpensed
|
0 | usd |
CY2023Q1 | us-gaap |
Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
|
1004000 | usd |
CY2022Q1 | us-gaap |
Amortization Of Deferred Loan Origination Fees Net
AmortizationOfDeferredLoanOriginationFeesNet
|
1298000 | usd |
CY2023Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
307000 | usd |
CY2022Q1 | us-gaap |
Amortization Of Financing Costs
AmortizationOfFinancingCosts
|
209000 | usd |
CY2023Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
120000 | usd |
CY2022Q1 | us-gaap |
Share Based Compensation
ShareBasedCompensation
|
82000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
-8000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accrued Interest Receivable Net
IncreaseDecreaseInAccruedInterestReceivableNet
|
133000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
-1101000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
|
387000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-113000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
|
-594000 | usd |
CY2023Q1 | us-gaap |
Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
|
-527000 | usd |
CY2022Q1 | us-gaap |
Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
|
-15000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
6577000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
|
3085000 | usd |
CY2023Q1 | sevn |
Payments For Originations Of Mortgage Loans Held For Investments
PaymentsForOriginationsOfMortgageLoansHeldForInvestments
|
0 | usd |
CY2022Q1 | sevn |
Payments For Originations Of Mortgage Loans Held For Investments
PaymentsForOriginationsOfMortgageLoansHeldForInvestments
|
90036000 | usd |
CY2023Q1 | sevn |
Payments For Additional Originations Of Mortgage Loans Held For Investments
PaymentsForAdditionalOriginationsOfMortgageLoansHeldForInvestments
|
1651000 | usd |
CY2022Q1 | sevn |
Payments For Additional Originations Of Mortgage Loans Held For Investments
PaymentsForAdditionalOriginationsOfMortgageLoansHeldForInvestments
|
3219000 | usd |
CY2023Q1 | sevn |
Repayment Of Loan Held For Investment
RepaymentOfLoanHeldForInvestment
|
51918000 | usd |
CY2022Q1 | sevn |
Repayment Of Loan Held For Investment
RepaymentOfLoanHeldForInvestment
|
48643000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
50267000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
|
-44612000 | usd |
CY2023Q1 | sevn |
Proceeds From Securities Sold Under Agreements To Repurchase
ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase
|
0 | usd |
CY2022Q1 | sevn |
Proceeds From Securities Sold Under Agreements To Repurchase
ProceedsFromSecuritiesSoldUnderAgreementsToRepurchase
|
130160000 | usd |
CY2023Q1 | sevn |
Repayments For Securities Sold Under Agreements To Repurchase
RepaymentsForSecuritiesSoldUnderAgreementsToRepurchase
|
38125000 | usd |
CY2022Q1 | sevn |
Repayments For Securities Sold Under Agreements To Repurchase
RepaymentsForSecuritiesSoldUnderAgreementsToRepurchase
|
101597000 | usd |
CY2023Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
318000 | usd |
CY2022Q1 | us-gaap |
Payments Of Debt Issuance Costs
PaymentsOfDebtIssuanceCosts
|
720000 | usd |
CY2023Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
13000 | usd |
CY2022Q1 | us-gaap |
Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
|
0 | usd |
CY2023Q1 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
5147000 | usd |
CY2022Q1 | us-gaap |
Payments Of Dividends
PaymentsOfDividends
|
3649000 | usd |
CY2023Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
-43603000 | usd |
CY2022Q1 | us-gaap |
Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
|
24194000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
13241000 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
|
-17333000 | usd |
CY2022Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
71067000 | usd |
CY2021Q4 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
26295000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
84308000 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
8962000 | usd |
CY2023Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
7408000 | usd |
CY2022Q1 | us-gaap |
Interest Paid Net
InterestPaidNet
|
1584000 | usd |
CY2023Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
3000 | usd |
CY2022Q1 | us-gaap |
Income Taxes Paid Net
IncomeTaxesPaidNet
|
47000 | usd |
CY2023Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
84300000 | usd |
CY2022Q1 | us-gaap |
Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
|
8953000 | usd |
CY2023Q1 | us-gaap |
Restricted Cash
RestrictedCash
|
8000 | usd |
CY2022Q1 | us-gaap |
Restricted Cash
RestrictedCash
|
9000 | usd |
CY2023Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
84308000 | usd |
CY2022Q1 | us-gaap |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
|
8962000 | usd |
CY2023Q1 | us-gaap |
Use Of Estimates
UseOfEstimates
|
The preparation of financial statements in conformity with GAAP requires us to make estimates and assumptions that affect reported amounts. Actual results could differ from those estimates. Significant estimates in the accompanying condensed consolidated financial statements include the allowance for credit losses and the fair value of financial instruments. | |
CY2023Q1 | us-gaap |
Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
|
Certain prior year amounts have been reclassified to conform to current year presentation. | |
CY2023Q1 | srt |
Mortgage Loans On Real Estate Number Of Loans
MortgageLoansOnRealEstateNumberOfLoans
|
25 | loan |
CY2022 | srt |
Mortgage Loans On Real Estate Number Of Loans
MortgageLoansOnRealEstateNumberOfLoans
|
27 | loan |
CY2023Q1 | sevn |
Loans Held For Investment Commitments
LoansHeldForInvestmentCommitments
|
674475000 | usd |
CY2022Q4 | sevn |
Loans Held For Investment Commitments
LoansHeldForInvestmentCommitments
|
727562000 | usd |
CY2023Q1 | sevn |
Financing Receivable Unfunded Loan Commitments
FinancingReceivableUnfundedLoanCommitments
|
45779000 | usd |
CY2022Q4 | sevn |
Financing Receivable Unfunded Loan Commitments
FinancingReceivableUnfundedLoanCommitments
|
49007000 | usd |
CY2023Q1 | srt |
Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
|
628696000 | usd |
CY2022Q4 | srt |
Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
|
678555000 | usd |
CY2023Q1 | us-gaap |
Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
|
617935000 | usd |
CY2022Q4 | us-gaap |
Financing Receivable Excluding Accrued Interest After Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestAfterAllowanceForCreditLoss
|
669929000 | usd |
CY2023Q1 | sevn |
Loans Receivable Weighted Average Coupon Rate Percentage
LoansReceivableWeightedAverageCouponRatePercentage
|
0.0857 | |
CY2022Q4 | sevn |
Loans Receivable Weighted Average Coupon Rate Percentage
LoansReceivableWeightedAverageCouponRatePercentage
|
0.0807 | |
CY2023Q1 | sevn |
Loans Receivable Average All In Yield Percentage
LoansReceivableAverageAllInYieldPercentage
|
0.0906 | |
CY2022Q4 | sevn |
Loans Receivable Average All In Yield Percentage
LoansReceivableAverageAllInYieldPercentage
|
0.0857 | |
CY2023Q1 | sevn |
Loans Receivable Weighted Average Libor Floor Percentage
LoansReceivableWeightedAverageLIBORFloorPercentage
|
0.0065 | |
CY2022Q4 | sevn |
Loans Receivable Weighted Average Libor Floor Percentage
LoansReceivableWeightedAverageLIBORFloorPercentage
|
0.0062 | |
CY2023Q1 | sevn |
Loans Receivable Weighted Average Term Of Maturity
LoansReceivableWeightedAverageTermOfMaturity
|
P3Y1M6D | |
CY2022 | sevn |
Loans Receivable Weighted Average Term Of Maturity
LoansReceivableWeightedAverageTermOfMaturity
|
P3Y3M18D | |
CY2023Q1 | sevn |
Mortgage Loans On Real Estate Weighted Average Risk Rating Of Portfolio
MortgageLoansOnRealEstateWeightedAverageRiskRatingOfPortfolio
|
2.9 | |
CY2022Q4 | sevn |
Mortgage Loans On Real Estate Weighted Average Risk Rating Of Portfolio
MortgageLoansOnRealEstateWeightedAverageRiskRatingOfPortfolio
|
2.9 | |
CY2022Q4 | srt |
Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
|
678555000 | usd |
CY2022Q4 | sevn |
Real Estate Companies Investment In Mortgage Loans On Real Estate Deferred Fees And Other Items
RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateDeferredFeesAndOtherItems
|
8626000 | usd |
CY2022Q4 | us-gaap |
Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
|
669929000 | usd |
CY2023Q1 | us-gaap |
Mortgage Loans On Real Estate Other Additions
MortgageLoansOnRealEstateOtherAdditions
|
1884000 | usd |
CY2023Q1 | sevn |
Mortgage Loan Additional Funding Deferred Fees And Other Items
MortgageLoanAdditionalFundingDeferredFeesAndOtherItems
|
-14000 | usd |
CY2023Q1 | sevn |
Mortgage Loan Additional Funding Net
MortgageLoanAdditionalFundingNet
|
1870000 | usd |
CY2023Q1 | sevn |
Mortgage Loan Repayments Gross
MortgageLoanRepaymentsGross
|
51743000 | usd |
CY2023Q1 | sevn |
Mortgage Loan Repayments Deferred Fees And Other Items
MortgageLoanRepaymentsDeferredFeesAndOtherItems
|
175000 | usd |
CY2023Q1 | srt |
Mortgage Loans On Real Estate Collections Of Principal
MortgageLoansOnRealEstateCollectionsOfPrincipal
|
51918000 | usd |
CY2023Q1 | sevn |
Amortization Of Deferred Loan Origination Fees Excluding Repayments Net
AmortizationOfDeferredLoanOriginationFeesExcludingRepaymentsNet
|
1004000 | usd |
CY2023Q1 | sevn |
Amortization Of Deferred Loan Origination Fees Excluding Repayments Net
AmortizationOfDeferredLoanOriginationFeesExcludingRepaymentsNet
|
1004000 | usd |
CY2023Q1 | sevn |
Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Purchase Discount Accretion
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstatePurchaseDiscountAccretion
|
1185000 | usd |
CY2023Q1 | sevn |
Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Purchase Discount Accretion
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstatePurchaseDiscountAccretion
|
1185000 | usd |
CY2023Q1 | srt |
Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
|
628696000 | usd |
CY2023Q1 | sevn |
Real Estate Companies Investment In Mortgage Loans On Real Estate Deferred Fees And Other Items
RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateDeferredFeesAndOtherItems
|
6626000 | usd |
CY2023Q1 | us-gaap |
Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
|
622070000 | usd |
CY2021Q4 | srt |
Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
|
590590000 | usd |
CY2021Q4 | sevn |
Real Estate Companies Investment In Mortgage Loans On Real Estate Deferred Fees And Other Items
RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateDeferredFeesAndOtherItems
|
19810000 | usd |
CY2021Q4 | us-gaap |
Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
|
570780000 | usd |
CY2022Q1 | us-gaap |
Mortgage Loans On Real Estate Other Additions
MortgageLoansOnRealEstateOtherAdditions
|
3304000 | usd |
CY2022Q1 | sevn |
Mortgage Loan Additional Funding Net
MortgageLoanAdditionalFundingNet
|
3304000 | usd |
CY2022Q1 | us-gaap |
Mortgage Loans On Real Estate New Mortgage Loans
MortgageLoansOnRealEstateNewMortgageLoans
|
91184000 | usd |
CY2022Q1 | us-gaap |
Mortgage Loans On Real Estate Other Deductions
MortgageLoansOnRealEstateOtherDeductions
|
1148000 | usd |
CY2022Q1 | us-gaap |
Mortgage Loans On Real Estate Period Increase Decrease
MortgageLoansOnRealEstatePeriodIncreaseDecrease
|
90036000 | usd |
CY2022Q1 | sevn |
Mortgage Loan Repayments Gross
MortgageLoanRepaymentsGross
|
48247000 | usd |
CY2022Q1 | srt |
Mortgage Loans On Real Estate Collections Of Principal
MortgageLoansOnRealEstateCollectionsOfPrincipal
|
48247000 | usd |
CY2022Q1 | sevn |
Amortization Of Deferred Loan Origination Fees Excluding Repayments Net
AmortizationOfDeferredLoanOriginationFeesExcludingRepaymentsNet
|
902000 | usd |
CY2022Q1 | sevn |
Amortization Of Deferred Loan Origination Fees Excluding Repayments Net
AmortizationOfDeferredLoanOriginationFeesExcludingRepaymentsNet
|
902000 | usd |
CY2022Q1 | sevn |
Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Purchase Discount Accretion
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstatePurchaseDiscountAccretion
|
5935000 | usd |
CY2022Q1 | sevn |
Sec Schedule1229 Real Estate Companies Investment In Mortgage Loans On Real Estate Purchase Discount Accretion
SECSchedule1229RealEstateCompaniesInvestmentInMortgageLoansOnRealEstatePurchaseDiscountAccretion
|
5935000 | usd |
CY2022Q1 | srt |
Mortgage Loans On Real Estate Face Amount Of Mortgages
MortgageLoansOnRealEstateFaceAmountOfMortgages
|
636831000 | usd |
CY2022Q1 | sevn |
Real Estate Companies Investment In Mortgage Loans On Real Estate Deferred Fees And Other Items
RealEstateCompaniesInvestmentInMortgageLoansOnRealEstateDeferredFeesAndOtherItems
|
14121000 | usd |
CY2022Q1 | us-gaap |
Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
|
622710000 | usd |
CY2023Q1 | srt |
Mortgage Loans On Real Estate Number Of Loans
MortgageLoansOnRealEstateNumberOfLoans
|
25 | loan |
CY2023Q1 | us-gaap |
Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
|
622070000 | usd |
CY2023Q1 | sevn |
Mortgage Loans On Real Estate Percentage Of Value Of Portfolio
MortgageLoansOnRealEstatePercentageOfValueOfPortfolio
|
1 | |
CY2022 | srt |
Mortgage Loans On Real Estate Number Of Loans
MortgageLoansOnRealEstateNumberOfLoans
|
27 | loan |
CY2022Q4 | us-gaap |
Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
|
669929000 | usd |
CY2022Q4 | sevn |
Mortgage Loans On Real Estate Percentage Of Value Of Portfolio
MortgageLoansOnRealEstatePercentageOfValueOfPortfolio
|
1 | |
CY2023Q1 | srt |
Mortgage Loans On Real Estate Number Of Loans
MortgageLoansOnRealEstateNumberOfLoans
|
25 | loan |
CY2023Q1 | us-gaap |
Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
|
622070000 | usd |
CY2023Q1 | sevn |
Mortgage Loans On Real Estate Percentage Of Value Of Portfolio
MortgageLoansOnRealEstatePercentageOfValueOfPortfolio
|
1 | |
CY2022 | srt |
Mortgage Loans On Real Estate Number Of Loans
MortgageLoansOnRealEstateNumberOfLoans
|
27 | loan |
CY2022Q4 | us-gaap |
Mortgage Loans On Real Estate
MortgageLoansOnRealEstate
|
669929000 | usd |
CY2022Q4 | sevn |
Mortgage Loans On Real Estate Percentage Of Value Of Portfolio
MortgageLoansOnRealEstatePercentageOfValueOfPortfolio
|
1 | |
CY2023Q1 | srt |
Mortgage Loans On Real Estate Number Of Loans
MortgageLoansOnRealEstateNumberOfLoans
|
25 | loan |
CY2023Q1 | sevn |
Mortgage Loans On Real Estate Percentage Of Value Of Portfolio
MortgageLoansOnRealEstatePercentageOfValueOfPortfolio
|
1 | |
CY2023Q1 | us-gaap |
Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
|
0 | usd |
CY2023Q1 | us-gaap |
Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
|
207168000 | usd |
CY2023Q1 | us-gaap |
Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
|
308164000 | usd |
CY2023Q1 | us-gaap |
Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
|
106738000 | usd |
CY2023Q1 | us-gaap |
Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
|
622070000 | usd |
CY2022 | srt |
Mortgage Loans On Real Estate Number Of Loans
MortgageLoansOnRealEstateNumberOfLoans
|
27 | loan |
CY2022Q4 | sevn |
Mortgage Loans On Real Estate Percentage Of Value Of Portfolio
MortgageLoansOnRealEstatePercentageOfValueOfPortfolio
|
1 | |
CY2022Q4 | us-gaap |
Financing Receivable Excluding Accrued Interest Year One Originated Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearOneOriginatedCurrentFiscalYear
|
206022000 | usd |
CY2022Q4 | us-gaap |
Financing Receivable Excluding Accrued Interest Year Two Originated Fiscal Year Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearTwoOriginatedFiscalYearBeforeCurrentFiscalYear
|
340818000 | usd |
CY2022Q4 | us-gaap |
Financing Receivable Excluding Accrued Interest Year Three Originated Two Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestYearThreeOriginatedTwoYearsBeforeCurrentFiscalYear
|
78448000 | usd |
CY2022Q4 | us-gaap |
Financing Receivable Excluding Accrued Interest Originated More Than Five Years Before Current Fiscal Year
FinancingReceivableExcludingAccruedInterestOriginatedMoreThanFiveYearsBeforeCurrentFiscalYear
|
44641000 | usd |
CY2022Q4 | us-gaap |
Financing Receivable Excluding Accrued Interest Before Allowance For Credit Loss
FinancingReceivableExcludingAccruedInterestBeforeAllowanceForCreditLoss
|
669929000 | usd |
CY2022Q4 | sevn |
Mortgage Loans On Real Estate Weighted Average Risk Rating Of Portfolio
MortgageLoansOnRealEstateWeightedAverageRiskRatingOfPortfolio
|
2.9 | |
CY2023Q1 | sevn |
Mortgage Loans On Real Estate Weighted Average Risk Rating Of Portfolio
MortgageLoansOnRealEstateWeightedAverageRiskRatingOfPortfolio
|
2.9 | |
CY2023Q1 | us-gaap |
Debt Instrument Collateral Amount
DebtInstrumentCollateralAmount
|
435490000 | usd |
CY2023Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
14582000 | shares |
CY2023Q1 | us-gaap |
Stock Repurchased During Period Shares
StockRepurchasedDuringPeriodShares
|
1503 | shares |
CY2023Q1 | us-gaap |
Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
|
13000 | usd |
CY2023Q1 | us-gaap |
Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
|
0.35 | |
CY2023Q1 | us-gaap |
Common Stock Dividends Per Share Declared
CommonStockDividendsPerShareDeclared
|
0.35 | |
CY2023Q1 | us-gaap |
Dividends Common Stock Cash
DividendsCommonStockCash
|
5147000 | usd |
CY2022Q1 | us-gaap |
Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
|
14505000 | shares |
CY2023Q1 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
0 | shares |
CY2023Q1 | dei |
Entity Number Of Employees
EntityNumberOfEmployees
|
0 | employee |
CY2023Q1 | sevn |
Base Management Fee Percent Fee Quarterly
BaseManagementFeePercentFeeQuarterly
|
0.00375 | |
CY2023Q1 | sevn |
Base Management Fee Percent Fee Annualized
BaseManagementFeePercentFeeAnnualized
|
0.015 | |
CY2023Q1 | sevn |
Base Management Fee
BaseManagementFee
|
1072000 | usd |
CY2022Q1 | sevn |
Base Management Fee
BaseManagementFee
|
1063000 | usd |
CY2022Q1 | sevn |
Management Incentive Fee
ManagementIncentiveFee
|
0 | usd |
CY2023Q1 | sevn |
Management Incentive Fee
ManagementIncentiveFee
|
0 | usd |
CY2023Q1 | sevn |
Reimbursement Of Shared Services Expenses
ReimbursementOfSharedServicesExpenses
|
643000 | usd |
CY2022Q1 | sevn |
Reimbursement Of Shared Services Expenses
ReimbursementOfSharedServicesExpenses
|
634000 | usd |
CY2022Q1 | us-gaap |
Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
|
14000 | shares |
CY2023Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14582000 | shares |
CY2023Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
7803000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss
NetIncomeLoss
|
11126000 | usd |
CY2023Q1 | us-gaap |
Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
|
67000 | usd |
CY2022Q1 | us-gaap |
Participating Securities Distributed And Undistributed Earnings Loss Basic
ParticipatingSecuritiesDistributedAndUndistributedEarningsLossBasic
|
70000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
7736000 | usd |
CY2023Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
7736000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
|
11056000 | usd |
CY2022Q1 | us-gaap |
Net Income Loss Available To Common Stockholders Diluted
NetIncomeLossAvailableToCommonStockholdersDiluted
|
11056000 | usd |
CY2022Q1 | us-gaap |
Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
|
14519000 | shares |
CY2023Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.53 | |
CY2023Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.53 | |
CY2022Q1 | us-gaap |
Earnings Per Share Diluted
EarningsPerShareDiluted
|
0.76 | |
CY2022Q1 | us-gaap |
Earnings Per Share Basic
EarningsPerShareBasic
|
0.76 | |
CY2023Q1 | sevn |
Financing Receivable Unfunded Loan Commitments
FinancingReceivableUnfundedLoanCommitments
|
45779000 | usd |